Research reports
Monoclonal antibody based enzyme-linked and chemiluminescent assays for the human interleukin-1 receptor antagonist Application to measure hIL-1ra levels in monocyte cultures and synovial fluids

https://doi.org/10.1016/0022-1759(94)90252-6Get rights and content

Abstract

Interleukin-1 receptor antagonist (IL-1ra) has the potential to counteract at least part of the biological effects of interleukin-1. The outcome of an inflammatory reaction may therefore be determined by the balance between IL-1 and IL-1ra, rather than by IL-1 alone. We have developed an immunoassay to address this issue as well as to assess the effects of anti-inflammatory agents on the expression of IL-1 and IL-1ra in vitro or in body fluids. Recombinant human IL-1ra was expressed in an E. coli system, purified to homogeneity, and used to derive monoclonal antibodies in mice as well as polyclonal antibodies in rabbits. A sandwich ELISA was constructed with F(ab′)2 fragments of a high affinity monoclonal antibody and the rabbit serum as a source of secondary antibody. The assay required no sample treatment to avoid interference by rheumatoid factor. The measuring range was 0.020-2 ng/ml. By labelling a second monoclonal antibody with an acridinium ester, a chemiluminescence assay with a wider measuring range (0.050–15 ng/ml) was generated. In accord with published data, we found that IL-1ra was secreted by human monocytes stimulated with LPS, Zymosan, IL-1α, or human IgG. After an induction phase of ca. 4 hours and depending on the stimulus, IL-1ra accumulated linearly for periods up to 96 h. IL-1ra levels in synovial fluids of 19 patients suffering from various inflammatory joint diseases were compared with the cytokine levels of IL-1β, IL-g, IL-8, and TNF-α. Highest positive correlations were found with IL-8 and IL-1β. In normal blood donors IL-1ra serum levels were 150–800 pg/ml (Median: 387 pg/ml). Owing to its sensitivity and large measuring range the newly developed assays appear to be suitable for measuring IL-1ra in cell cultures as well as in biological fluids.

References (29)

  • W.P. Arend et al.

    IL-1 receptor antagonist and IL-1-beta production in human monocytes are regulated differentely

    J. Immunol.

    (1991)
  • F. Bazzoni et al.

    Phagocytosing neutrophils produce and release high amounts of the neutrophilactivating peptide 1/interleukin 8

    J. Exp. Med.

    (1991)
  • G. Buell et al.

    Optimizing the expression in E. coli of a synthetic gene encoding somatomedin-C (IGF-1)

    Nucleic Acids Res.

    (1985)
  • C.A. Dinarello et al.

    Mechanisms of disease-The role of interleukin-1 in disease

    New Engl. J. Med.

    (1993)
  • Cited by (17)

    View all citing articles on Scopus
    View full text